GZB-33583-46682
4 vaccinations
9 coded responses
43 check-ins
9 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 786 / TX
- Registered
- 2021-06-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
KG9-18417-43139
Child or adolescent in my care · Male · 2022-06-21
EDX-28282-03536
Child or adolescent in my care · Male · 2022-07-05
Timeline
-
2021-05-25
Dose 1 — Pfizer-BioNTech
-
2021-06-15
Registered in v-safe
-
2021-06-15
Dose 2 — Pfizer-BioNTech
- 2021-06-15
-
2021-06-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-06-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-06-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2021-06-19
Survey response — days 1–6 daily, dose 2MedDRA: Alopecia — Feeling: Good · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesFree text: Unusual hair lossMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
- 2021-06-21
-
2021-06-22
Health check-in — day 7, dose 2Feeling: Good · Headache, Joint pains · Be unable to do your normal daily activitiesAdult check-in
-
2021-06-29
Survey response — day 14, dose 2MedDRA: Alopecia, Arthralgia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Worsening hair loss. Continuing moderate joint pain.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-06
Survey response — day 21, dose 2MedDRA: Alopecia, Arthralgia, Joint stiffness, Office visit — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Worsened severe joint pain, new moderate joint stiffness, continued severe hair loss · Healthcare visit (other): PCP officeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-06
Report sent to call center — day 21, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-13
Survey response — day 28, dose 2MedDRA: Alopecia, Arthralgia, Joint stiffness, Weight increased — Feeling: Good · Be unable to do your normal daily activitiesFree text: Worsened moderate weight gain, continued severe hair loss. Joint pain has improved and is mostly back down to the mild level that began after my first shot. Joint stiffness has resolved.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-14
Call successfulCompleted over the phone
- 2021-07-20
-
2021-07-27
Survey response — day 42, dose 2MedDRA: Arthralgia, Arthritis, Joint stiffness — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Joint pain is back up to a moderate some days. One finger joint is back to being inflamed and stiff.MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-16
- 2021-12-14
-
2021-12-31
Dose 3 — Pfizer-BioNTech
-
2022-01-01
Survey response — days 1–6 daily, dose 3MedDRA: Dizziness — Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
-
2022-01-02
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-04
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2022-01-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2022-01-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Joint pains, Fatigue or tirednessAdult check-in
- 2022-01-07
- 2022-01-14
- 2022-01-21
- 2022-01-28
-
2022-02-04
Survey response — day 35, dose 3MedDRA: Intervertebral disc protrusion, Office visit — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Slipped disc in back. This is undoubtedly unrelated to the vaccine, but I'm reporting it for the sake of accurate control group comparison. · Healthcare visit (other): ChiropractorMedDRA releases: 2024-11 · check-in free text available
-
2022-02-04
Report sent to call center — day 35, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2022-02-11
- 2022-02-23
- 2022-04-01
- 2022-07-01
-
2022-09-06
Dose 4 — Pfizer-BioNTech
- 2022-09-06
-
2022-09-07
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-09-08
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-09-09
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-09-10
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-09-11
- 2022-09-12
-
2022-09-20
Survey response — day 14, dose 4MedDRA: Abortion spontaneous — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: MiscarriageMedDRA releases: 2024-11 · check-in free text available
-
2022-09-20
Report sent to call center — day 14, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-09-21
Call successfulDoes not wish to fill out VAERS report
-
2022-09-21
Call successfulDoes not wish to fill out VAERS report
-
2022-09-27
Survey response — day 21, dose 4MedDRA: Malaise — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Covid symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-09-27
Report sent to call center — day 21, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-09-29
-
2022-09-29
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-04
- 2022-10-11
- 2022-10-18
- 2022-12-08
- 2023-03-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-25 | Pfizer-BioNTech | |
| 2 | 2021-06-15 | Pfizer-BioNTech | |
| 3 | 2021-12-31 | Pfizer-BioNTech | No |
| 4 | 2022-09-06 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-06 | Successful 2021-07-14 |
Completed over the phone |
| 2022-02-04 | Successful 2022-09-21 |
Does not wish to fill out VAERS report |
| 2022-09-20 | Successful 2022-09-21 |
Does not wish to fill out VAERS report |
| 2022-09-27 | Successful 2022-09-29 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Unusual hair loss
Release 9 — day 14, dose 2
Symptoms: Worsening hair loss. Continuing moderate joint pain.
Release 9 — day 21, dose 2
Symptoms: Worsened severe joint pain, new moderate joint stiffness, continued severe hair loss
Healthcare visit (other): PCP office
Release 9 — day 28, dose 2
Symptoms: Worsened moderate weight gain, continued severe hair loss. Joint pain has improved and is mostly back down to the mild level that began after my first shot. Joint stiffness has resolved.
Release 9 — day 42, dose 2
Symptoms: Joint pain is back up to a moderate some days. One finger joint is back to being inflamed and stiff.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Dizziness
Release 11 — day 35, dose 3
Symptoms: Slipped disc in back. This is undoubtedly unrelated to the vaccine, but I'm reporting it for the sake of accurate control group comparison.
Healthcare visit (other): Chiropractor
Release 12 — day 14, dose 4
Symptoms: Miscarriage
Release 12 — day 21, dose 4
Symptoms: Covid symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Alopecia | ✓ | ✓ | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Arthritis | ✓ | · | ✓ |
| SD | Intervertebral disc protrusion | · | · | ✓ |
| SD | Joint stiffness | ✓ | ✓ | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Weight increased | ✓ | ✓ | ✓ |
| SRO | Alopecia | ✓ | ✓ | ✓ |
| SRO | Dizziness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release